Futura Medical plc (AIM:FUM)

Market Cap	7.39M -78.3%
Revenue (ttm)	7.93M -5.6%
Net Income	-6.29M
EPS	-0.02
Shares Out	581.33M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	631,213
Average Volume	3,377,500
Open	1.120
Previous Close	1.273
Day's Range	1.115 - 1.239
52-Week Range	0.989 - 15.000
Beta	0.21
RSI	52.23
Earnings Date	Apr 10, 2026

About Futura Medical

Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company’s lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 14
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: FUM